BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2430328)

  • 21. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of lymphocytes in effusions of patients with tuberculosis or malignant disease.
    Falcão RP; Bottura C
    Clin Exp Immunol; 1981 Jul; 45(1):201-4. PubMed ID: 6975680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkaline phosphatase in pleural effusions.
    Lone MA; Wahid A; Saleem SM; Koul P; Dhobi GN; Shahnawaz A
    Indian J Chest Dis Allied Sci; 2003; 45(3):161-3. PubMed ID: 12866632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.
    Sehested M; Ralfkjaer E; Rasmussen J
    Acta Cytol; 1983; 27(2):124-7. PubMed ID: 6340401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders.
    Werle B; Sauckel K; Nathanson CM; Bjarnadottir M; Spiess E; Ebert W; Abrahamson M
    Biol Chem; 2003 Feb; 384(2):281-7. PubMed ID: 12675521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymes in benign and malignant effusions.
    Teloh HA
    Ann Clin Lab Sci; 1977; 7(4):361-3. PubMed ID: 900863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
    Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
    Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
    Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions.
    Antic T; Gong Y; Sneige N
    Diagn Cytopathol; 2012 Apr; 40(4):311-5. PubMed ID: 22431319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological diagnosis of serous effusions in a cancer hospital in Brazil.
    Oyafuso MS; Longatto Filho A; Bortolan J; Rahal P; Bisi H; Lombardo V
    Pathologica; 1996 Apr; 88(2):128-31. PubMed ID: 8927447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions].
    Ohtani H
    Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770
    [No Abstract]   [Full Text] [Related]  

  • 34. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of biochemical tests in the diagnosis of exudative pleural effusions.
    Ernam D; Atalay F; Hasanoglu HC; Kaplan O
    Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fc receptors in the differentiation of mesothelial cells from malignant cells in effusions.
    Chandra M; Nayar M
    Acta Cytol; 1990; 34(4):582-3. PubMed ID: 2375229
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enzyme cytochemical investigations on pleural effusions (author's transl)].
    Eckert H
    Z Erkr Atmungsorgane; 1977; 148(3):321-30. PubMed ID: 145738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytologic application of carcinoembryonic antigen for the discrimination of malignant from benign serous effusions.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Athanassiadis PP; Mandragos CE
    Cancer Detect Prev; 1985; 8(1-2):247-54. PubMed ID: 4064045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the interpretation of atypical cells in pleural and peritoneal effusion.
    Soendergaard K
    Acta Cytol; 1977; 21(3):413-6. PubMed ID: 268121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.